摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[1,3]dioxolo[4,5-b]acridin-10(5H)-one | 5876-55-1

中文名称
——
中文别名
——
英文名称
[1,3]dioxolo[4,5-b]acridin-10(5H)-one
英文别名
5h-[1,3]Dioxolo[4,5-b]acridin-10-one
[1,3]dioxolo[4,5-b]acridin-10(5H)-one化学式
CAS
5876-55-1
化学式
C14H9NO3
mdl
——
分子量
239.23
InChiKey
IISARRDJDFHWRO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    >300 °C (decomp)
  • 沸点:
    433.0±45.0 °C(Predicted)
  • 密度:
    1.409±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    18
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    47.6
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    作用下, 以 二甲基亚砜 为溶剂, 以84%的产率得到[1,3]dioxolo[4,5-b]acridin-10(5H)-one
    参考文献:
    名称:
    二甲基亚砜辅助的铜(0)催化的N-芳基靛红分子内脱羰重排导致a啶酮
    摘要:
    摘要本文描述了在空气气氛和无添加剂条件下,Cu(0)催化易得的N-芳基isatins在溶剂和无添加剂条件下通过Cu(0)催化的分子内脱羰重排的第一个例子,导致各种重要的生物学上重要的good啶类化合物产量。提出了这种新颖的转化方法,该方法需要通过依次进行DMSO辅助的Cu插入酰胺CN键,CO挤出,Cu迁移,还原消除和DMSO辅助的质子迁移过程,在单个化学步骤中涉及多种类型的键裂解和形成。 。
    DOI:
    10.1016/j.cclet.2019.10.043
点击查看最新优质反应信息

文献信息

  • Access to acridones by tandem copper(<scp>i</scp>)-catalyzed electrophilic amination/Ag(<scp>i</scp>)-mediated oxidative annulation of anthranils with arylboronic acids
    作者:Chun-Yong Jiang、Hui Xie、Zhuo-Jun Huang、Jing-Yi Liang、Yan-Xia Huang、Qiu-Ping Liang、Jun-Yi Zeng、Binhua Zhou、Shang-Shi Zhang、Bing Shu
    DOI:10.1039/d1ob01586a
    日期:——
    An efficient and practical approach for the synthesis of medicinally important acridones was developed from anthranils and commercially available arylboronic acids by a tandem copper(I)-catalyzed electrophilic amination/Ag(I)-mediated oxidative annulation strategy. This new and straightforward protocol displayed a broad substrate scope (25 examples) and high functional group tolerance. What's more
    通过串联铜()催化的亲电胺化/银()介导的氧化环化策略,从邻氨基苯甲醚和市售芳基硼酸开发了一种有效且实用的合成药用重要吖啶酮的方法。这种新的、简单的方案显示了广泛的底物范围(25 个示例)和高官能团耐受性。此外,还提出了一种可能的机制建议。
  • Synthesis of Polycyclic Indolone and Pyrroloindolone Heterocycles via the Annulation of Indole- and Pyrrole-2-Carboxylate Esters with Arynes
    作者:Yeeman Ramtohul、Robert Giacometti
    DOI:10.1055/s-0029-1217535
    日期:2009.7
    A mild and general method for the synthesis of a variety of polycyclic indolone and pyrroloindolone heterocycles via the reaction of indole- and pyrrole-2-carboxylate esters with arynes has been developed.
    开发了一种温和且通用的方法,通过吲哚-和吡咯-2-羧酸酯与芳香烯的反应合成多种多环吲哚和吡咯吲哚杂环化合物。
  • Use of N-lithiated ethyl anthranilates as 1,4-dipole equivalents in 1,4-dipolearyne cycloaddition: A novel approach to the synthesis of acridones
    作者:Subhash P. Khanapure、Baburao M. Bhawal、Edward R. Biehl
    DOI:10.1016/0040-4039(90)80169-m
    日期:1990.1
    A new strategy for acridones based on 1,4-dipolar cycloaddition of N-lithiated ethyl anthranilates, which function as 1,4-dipole equivalents, with arynes is reported.
    报道了基于N-锂化邻氨基苯甲酸乙酯的1,4-偶极环加成的a啶酮的新策略,其与芳烃起1,4-偶极当量的作用。
  • Tricyclic heterocyclic derivatives
    申请人:IMPERIAL CHEMICAL INDUSTRIES PLC
    公开号:EP0471516A1
    公开(公告)日:1992-02-19
    The invention relates to tricyclic heterocyclic derivatives, or pharmaceutically-acceptable salts or in vivo hydrolysable esters thereof, which possess anti-cancer activity. The invention also relates to processes for the manufacture of said tricyclic heterocyclic derivatives, to novel pharmaceutical compositions containing them and to the use of said tricyclic heterocyclic derivatives in the manufacture of a medicament for the production of an anti-cancer effect. The invention provides an optionally substituted tricyclic heterocyclic derivative of the formula I wherein A together with the adjacent vinylene group of the 4-oxo-1,4-dihydropyrid-1-yl ring completes a benzene or pyridine ring;    R¹ and R², which may be the same or different, each is (1-4C)alkyl or (1-4C)alkoxy;    and R³ is hydrogen, (1-4C)alkyl or (1-4C)alkoxy;    or a pharmaceutically-acceptable salt or in vivo hydrolysable ester thereof.
    该发明涉及三环杂环衍生物,或其药用盐或体内可水解酯,具有抗癌活性。该发明还涉及制备所述三环杂环衍生物的方法,含有它们的新型药物组合物以及利用所述三环杂环衍生物制造抗癌药物以产生抗癌效果的用途。该发明提供了公式I的可选择取代的三环杂环衍生物,其中A与4-氧代-1,4-二氢吡啶-1-基环的相邻乙烯基团共同形成苯环或吡啶环;R¹和R²,可以相同也可以不同,分别是(1-4C)烷基或(1-4C)烷氧基;R³是氢,(1-4C)烷基或(1-4C)烷氧基;或其药用盐或体内可水解酯。
  • Copper-Catalyzed Aerobic Oxidative CH and CC Functionalization of 1-[2-(Arylamino)aryl]ethanones Leading to Acridone Derivatives
    作者:Jipan Yu、Haijun Yang、Yuyang Jiang、Hua Fu
    DOI:10.1002/chem.201204169
    日期:2013.3.25
    Efficient coppercatalyzed aerobic oxidative CH and CC functionalization of 1‐[2‐(arylamino)aryl]ethanones leading to acridones has been developed. The procedure involves cleavage of aromatic CH and acetyl CC bonds with intramolecular formation of a diarylketone bond. The protocol uses inexpensive Cu(O2CCF3)2 as catalyst, pyridine as additive, and economical and environmentally friendly oxygen
    已经开发出有效的铜催化需氧氧化CH和CC功能化的1- [2-(芳基氨基)芳基]乙炔导致a啶酮。该过程涉及的切割芳族C  H和乙酰Ç  C键与分子内形成一个二芳基键的。该方案使用廉价的Cu(O 2 CCF 3)2作为催化剂,吡啶作为添加剂,经济和环境友好的氧气作为氧化剂,并以中等至良好的收率获得了具有各种官能团的相应的cri啶。
查看更多